BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:HRS-8364 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of HRS-8364\, from ClinicalTrials.gov estima
 tes.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07446153-11112@assetmemo.bio
DTSTAMP:20261121T005702Z
DTSTART;VALUE=DATE:20281231
DTEND;VALUE=DATE:20290101
SUMMARY:HRS-8364: Phase 1/2 readout est. (NCT07446153)
DESCRIPTION:HRS-8364\, phase 1/2\, Advanced Solid Tumors.\nStudy: A Clinica
 l Study of HRS-8364 in the Treatment of Advanced Solid Tumor Subjects\nEst
 imated primary completion: December 2028. This is a ClinicalTrials.gov est
 imate\, not a confirmed readout date\, and it can move.\nDrug page: https:
 //assetmemo.bio/drug/hrs-8364#upcoming-events\nRegistry record: https://cl
 inicaltrials.gov/study/NCT07446153
URL:https://assetmemo.bio/drug/hrs-8364#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
